A comprehensive guide to antibody and T-cell responses in type 1 diabetes

Tissue Antigens

Volumn 62, Issue 5, 2003, Pages 359-377

  Lieberman, S M ^a   DiLorenzo, T P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cells; Antigens; Autoimmunity; CD4 T cells; CD8 T cells; Epitopes; NOD mice; Type 1 diabetes

Indexed keywords

AMYLIN; B LYMPHOCYTE ANTIBODY; B LYMPHOCYTE ANTIGEN; HEAT SHOCK PROTEIN 60; INSULIN; PREPROINSULIN; PROINSULIN; PROTEIN S100B;

ANTIBODY RESPONSE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELLULAR DISTRIBUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGENS; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; T-LYMPHOCYTES; THYMUS GLAND;

ANIMALIA;

EID: 0242364727     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2003.00152.x     Document Type: Review

References (99)

1. Hayles AB, Kennedy RLJ, Beahrs OH et al. Exophthalmic goiter in children. J Clin Endocrinol Metab 1959: 19: 138-51.
2. Ungar B, Stocks AE, Martin FIR et al. Intrinsic-factor antibody, parietal-cell antibody, and latent pernicious anaemia in diabetes mellitus. Lancet 1968: 2: 415-8.
3. LeCompte PM. 'Insulitis' in early juvenile diabetes. Arch Pathol 1958: 66: 450-7.
4. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974: 2: 1279-83.
5. Nerup J, Platz P, Andersen OO et al. HL-A antigens and diabetes mellitus. Lancet 1974: 2: 864-6.
6. Lendrum R, Nelson PG, Pyke DA et al. Islet-cell, thyroid, and gastric autoantibodies in diabetic identical twins. BMJ 1976: 1: 553-5.
7. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983: 222: 1337-9.
8. Yu L, Robles DT, Abiru N et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000: 97: 1701-6.
9. Kuglin B, Gries FA, Kolb H. Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 1988: 37: 130-2.
10. Lan MS, Wasserfall C, Maclaren NK et al. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1996: 93: 6367-70.
11. Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990: 347: 151-6.
12. r isoform of glutamic acid decarboxylase. Diabetes 1993: 42: 631-6.
13. Kaufman DL, Erlander MG, Clare-Salzler M et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992: 89: 283-92.
14. Schwartz HL, Chandonia JM, Kash SF et al. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 1999: 287: 983-99.
15. r tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995: 96: 1506-11.
16. Rabin DU, Pleasic SM, Palmer-Crocker R et al. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992: 41: 183-6.
17. Lampasona V, Bearzatto M, Genovese S et al. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 1996: 157: 2707-11.
18. Hawkes CJ, Wasmeier C, Christie MR et al. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 1996: 45: 1187-92.
19. Lu J, Li Q, Xie H et al. Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 1996: 93: 2307-11.
20. Wasmeier C, Hutton JC. Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem 1996: 271: 18161-70.
21. Kawasaki E, Yu L, Rewers MJ et al. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes 1998: 47: 733-42.
22. Verge CF, Gianani R, Kawasaki E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996: 45: 926-33.
23. Castano L, Russo E, Zhou L et al. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab 1991: 73: 1197-201.
24. Elias D, Markovits D, Reshef T et al. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 1990: 87: 1576-80.
25. Horvath L, Cervenak L, Oroszlan M et al. Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol Lett 2002: 80: 155-62.
26. Pietropaolo M, Castano L, Babu S et al. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 1993: 92: 359-71.
27. Roep BO, Duinkerken G, Schreuder GM et al. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 1996: 26: 1285-9.
28. Chang YH, Hwang J, Shang HF et al. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM. Diabetes 1996: 45: 408-14.
29. Abulafia-Lapid R, Gillis D, Yosef O et al. T cells and autoantibodies to human HSP70 in Type 1 diabetes in children. J Autoimmun 2003: 20: 313-21.
30. Qin HY, Mahon JL, Atkinson MA et al. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J Autoimmun 2003: 20: 237-45.
31. Inman LR, McAllister CT, Chen L et al. Autoantibodies to the GLUT-2 glucose transporter of β cells in insulin-dependent diabetes mellitus of recent onset. Proc Natl Acad Sci USA 1993: 90: 1281-4.
32. Honeyman MC, Cram DS, Harrison LC. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes 1993: 42: 626-30.
33. Kasimiotis H, Myers MA, Argentaro A et al. Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes 2000: 49: 555-61.
34. 65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 1996: 97: 2772-83.
35. Buschard K, Josefsen K, Horn T et al. Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet 1993: 342: 840.
36. Dotta F, Gianani R, Previti M et al. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes 1996: 45: 1193-6.
37. Gillard BK, Thomas JW, Nell LJ et al. Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus. J Immunol 1989: 142: 3826-32.
38. Tisch R, Yang XD, Singer SM et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993: 366: 72-5.
39. Bonifacio E, Atkinson M, Eisenbarth G et al. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 2001: 50: 2451-8.
40. Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure. Diabetologia 2003: 46: 305-21.
41. Serreze DV, Leiter EH. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr Dir Autoimmun 2001: 4: 31-67.
42. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002: 3: 235-49.
43. Peakman M, Stevens EJ, Lohmann T et al. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest 1999: 104: 1449-57.
44. Nepom GT, Lippolis JD, White FM et al. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci USA 2001: 98: 1763-8.
45. + T cells in autoimmune diabetes. Proc Natl Acad Sci USA 2003: 100: 8384-8.
46. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993: 366: 69-72.
47. Zechel MA, Elliott JF, Atkinson MA et al. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J Autoimmun 1998: 11: 83-95.
48. Chao CC, Sytwu HK, Chen EL et al. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. Proc Natl Acad Sci USA 1999: 96: 9299-304.
49. Atkinson MA, Bowman MA, Campbell L et al. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994: 94: 2125-9.
50. Rudy G, Stone N, Harrison LC et al. Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1995: 1: 625-33.
51. Schloot NC, Roep BO, Wegmann DR et al. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia 1997: 40: 332-8.
52. Endl J, Otto H, Jung G et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 1997: 99: 2405-15.
53. Boyton RJ, Lohmann T, Londei M et al. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int Immunol 1998: 10: 1765-76.
54. Herman AE, Tisch RM, Patel SD et al. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. J Immunol 1999: 163: 6275-82.
55. Reijonen H, Novak EJ, Kochik S et al. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 2002: 51: 1375-82.
56. Wucherpfennig KW. Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr Opin Immunol 2001: 13: 650-6.
57. Wicker LS, Chen SL, Nepom GT et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 1996: 98: 2597-603.
58. Patel SD, Cope AP, Congia M et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR (α1*0101,β1*0401) transgenic mice. Proc Natl Acad Sci USA 1997: 94: 8082-7.
59. Daniel D, Gill RG, Schloot N et al. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995: 25: 1056-62.
60. Alleva DG, Crowe PD, Jin L et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 2001: 107: 173-80.
61. Halbout P, Briand JP, Becourt C et al. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J Immunol 2002: 169: 2436-43.
62. Chen W, Bergerot I, Elliott JF et al. Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol 2001: 167: 4926-35.
63. Congia M, Patel S, Cope AP et al. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci USA 1998: 95: 3833-8.
64. Durinovic-Bello I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996: 45: 795-800.
65. Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 1998: 4: 231-9.
66. Hawkes CJ, Schloot NC, Marks J et al. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 2000: 49: 356-66.
67. Trembleau S, Penna G, Gregori S et al. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. J Immunol 2000: 165: 6748-55.
68. Elias D, Reshef T, Birk OS et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA 1991: 88: 3088-91.
69. Birk OS, Elias D, Weiss AS et al. NOD mouse diabetes: the ubiquitous mouse hsp60 is a β-cell target antigen of autoimmune T cells. J Autoimmun 1996: 9: 159-66.
70. Abulafia-Lapid R, Elias D, Raz I et al. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmun 1999: 12: 121-9.
71. Raz I, Elias D, Avron A et al. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001: 358: 1749-53.
72. Karges W, Hammond-McKibben D, Gaedigk R et al. Loss of self-tolerance to ICA69 in nonobese diabetic mice. Diabetes 1997: 46: 1548-56.
73. Karges W, Gaedigk R, Hui MF et al. Molecular cloning of murine ICA69: diabetes-prone mice recognize the human autoimmune-epitope, Tep69, conserved in splice variants from both species. Biochim Biophys Acta 1997: 1360: 97-101.
74. null nonobese diabetic mice develop diabetes, but resist disease acceleration by cyclophosphamide. J Immunol 2002: 168: 475-82.
75. Winer S, Tsui H, Lau A et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 2003: 9: 198-205.
76. Achenbach P, Kelemen K, Wegmann DR et al. Spontaneous peripheral T-cell responses to the IA-2β (phogrin) autoantigen in young nonobese diabetic mice. J Autoimmun 2002: 19: 111-6.
77. Arden SD, Roep BO, Neophytou PI et al. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest 1996: 97: 551-61.
78. Gurr W, Yavari R, Wen L et al. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes 2002: 51: 339-46.
79. Wong FS, Karttunen J, Dumont C et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 1999: 5: 1026-31.
80. Martinez NR, Augstein P, Moustakas AK et al. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest 2003: 111: 1365-71.
81. Trudeau JD, Kelly-Smith C, Verchere CB et al. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 2003: 111: 217-23.
82. Kimura K, Kawamura T, Kadotani S et al. Peptide-specific cytotoxicity of T lymphocytes against glutamic acid decarboxylase and insulin in type 1 diabetes mellitus. Diabetes Res Clin Pract 2001: 51: 173-9.
83. Hutton JC, Eisenbarth GS. A pancreatic β-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Proc Natl Acad Sci USA 2003: 100: 8626-8.
84. Panagiotopoulos C, Qin H, Tan R et al. Identification of a β-cell specific MHC class I restricted epitope in type 1 diabetes. Diabetes 2003: 52: A46 [Abstract].
85. Panina-Bordignon P, Lang R, van Endert PM et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 1995: 181: 1923-7.
86. Quinn A, McInerney MF, Sercarz EE. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. J Immunol 2001: 167: 1748-57.
87. Takahashi K, Honeyman MC, Harrison LC. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific. Clin Immunol 2001: 99: 360-4.
88. Thebault-Baumont K, Dubois-Laforgue D, Krief P et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 2003: 111: 851-7.
89. Diez J, Park Y, Zeller M et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes 2001: 50: 895-900.
90. Princiotta MF, Finzi D, Qian SB et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003: 18: 343-54.
91. Wegmann DR, Norbury-Glaser M, Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 1994: 24: 1853-7.
92. + T cell population comprises multiple antigenic specificities. Clin Immunol 2002: 105: 332-41.
93. null NOD mice. Diabetes 1999: 48: 469-77.
94. g7 tetramers. Proc Natl Acad Sci USA 2000: 97: 14596-601.
95. Zekzer D, Wong FS, Ayalon O et al. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J Clin Invest 1998: 101: 68-73.
96. Bockova J, Elias D, Cohen IR. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J Autoimmun 1997: 10: 323-9.
97. Kudva YC, Deng YJ, Govindarajan R et al. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. Hum Immunol 2001: 62: 1099-105.
98. Kelemen K, Wegmann DR, Hutton JC. T-cell epitope analysis on the autoantigen phogrin (IA-2β) in the nonobese diabetic mouse. Diabetes 2001: 50: 1729-34.
99. Miyazaki I, Cheung RK, Gaedigk R et al. T cell activation and anergy to islet cell antigen in type I diabetes. J Immunol 1995: 154: 1461-9.